Search - tctmd.com

Displaying 381 - 400 of 527

Sort: Relevancy | Date

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It Transfemoral Mitral Valve Replacement!

Presentation TCT 2017

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It an Annuloplasty Device!

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Ralph Stephan von Bardeleben

October 31, 2017

Presentation TCT 2017

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It an Annuloplasty Device!

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Ralph Stephan von Bardeleben

October 31, 2017

Presentation TCT 2017

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It Edge-to-Edge Repair!

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Colin M. Barker

October 31, 2017

Presentation TCT 2017

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

Presenter: Vinayak Bapat, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD

October 31, 2017

Presentation ISCTR 2017

Device Therapy for Mitral and Tricuspid Valve Disease

Presenter: John Laschinger

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Todd Neale

October 12, 2017

Advertisement

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Early Pilot Study Results Show Symptom Improvement With TMVR

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It an Annuloplasty Device!

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It an Annuloplasty Device!

Flash Debate: If I Could Only Have One Transcatheter Therapy for Mitral Regurgitation - Make It Edge-to-Edge Repair!

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Device Therapy for Mitral and Tricuspid Valve Disease

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content